INTRODUCTION
Antimicrobial peptides (AMPs) are host defense molecules universal in the innate immune systems of both invertebrates and vertebrates. Because these ancient molecules remain potent after millions of years, they are regarded as important templates for developing a new generation of antimicrobials to combat antibiotic resistant superbugs, HIV-1 and cancer (1) (2) (3) (4) (5) (6) (7) (8) (9) . A clear growth of AMP research started in the 1980s owing to the discoveries of insect cecropins by Hans Boman, human ␣-defensins by Robert Lehrer and magainins by Michael Zasloff (10) (11) (12) . It is now accepted that the functional roles of AMPs are not limited to antimicrobial. Natural AMPs can have other functions such as apoptosis, wound healing and immune modulation. In addition, a balanced expression of AMPs is so important that either under or over-expression is related to human diseases (3) (4) (5) .
With the increase of such peptides annually, it was realized in the 1990s that a database would be useful to help manage the basic information for AMPs. To our knowledge, Alex Tossi et al. built the first such database for plant and animal AMPs in 1998 (13) . Unfortunately, this resource is no longer accessible online. In 2004, both the APD and AN-TIMIC were published. In 2012, ANTIMIC with 1700 entries (14) was replaced by DAMPD with a reduced number of 1232 entries (15) . The 2004 version of the antimicrobial peptide database (APD) with 525 AMPs (16) was widely accepted and utilized. In 2009, it was updated to the APD2 with 1228 entries (17) . Since the publication of the APD2, the database web hits increased exponentially (over 1 million in 2014). One of the most important reasons for this could be that the APD registers AMPs with a set of defined criteria and is regularly updated by an investigator in the AMP field. Furthermore, new features are added to the database continuously. In addition, each entry is highly integrated with additional peptide information covering various aspects of AMPs. This original database inspired the construction of more recent databases (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) . To help users better use this resource, here we summarize the main features of this updated database, which we refer to as the APD3. We also highlight multiple applications of this database in both research and education.
DATABASE MAIN FEATURES
To generate a clean data set, the APD3 has set up criteria for peptide registration. This database currently focuses on (i) natural AMPs with (ii) a known amino acid sequence, (iii) biological activity and (iv) a size less than 100 residues. More recently, the polypeptide size was further relaxed to 200 residues so that important human antimicrobial proteins can be included. A unique and powerful feature of the APD3 is that its search interface consists of a pipeline of search functions. The more one selects or enters, the less one will get. Without activating anything in the interface, a simple search returns all the peptides in the database (cur-rent total 2619). The users can filter the information freely at their will. To make it more convenient, the APD3 has enhanced the search interface by re-grouping the existing search icons into functional zones based on information types and by adding new search icons for peptide activity. At the bottom of the search page, users can sort the information based on peptide APD ID (default), net charge, length and hydrophobic content. In the following, we briefly describe the main features of the current APD3, ranging from peptide search, prediction, statistics and educational web pages to additional tools. (30), users can also view other related structures and properties of the same peptide. Version 3 also annotated 155 structures suggested by circular dichroism (CD), which provides clear evidence for helical structures. Although there are different schemes in the literature for structural classification (1-6), the APD3 has adopted a unified classification proposed by Wang (9) . The four peptide classes are ␣, ␤, ␣␤ and non-␣␤. Currently, the ␣ family contains 362 AMPs with known ␣-helical structures. The ␤ family is composed of 98 peptides with a ␤-sheet structure. While the ␣␤ family holds 98 AMPs with both ␣ and ␤ structures, 9 peptides in the non-␣␤ family have neither ␣ nor ␤ structures. Such peptide counts can be obtained from the search interface under 'structure'. Because not all peptides have known 3D structures, the APD3 has also adopted a universal classification system based on the covalent bonding patterns of polypeptide chains (31) . In this unified classification, the first class ( (one at a time). Thus, users can obtain a set of AMPs that are known to have an antimicrobial effect on any pathogen of interest as long as they have been determined and registered into the database. The mechanism of action, when known, is also described in the additional information field. One can use the BB keys (Table 3) to search for such information (17) . For example, we obtained 24 peptides that bind to lipid II to inhibit cell wall synthesis by entering BBW into the 'Name' field. In the additional information field, the APD3 also started to annotate animal models used to test the peptide efficacy in vivo. At present, a search of 'animal model' returned 40 peptides. For additional information, users can refer to the original articles using the links provided by the APD3. 8. The year of AMP discovery and author search. The APD3 also enabled a search of AMPs based on the year of discovery or an author. Based on this, we found ≈100 new natural AMPs per year since 2000 (32) . Michael Conlon (33) is one of the most productive contributors since his name is linked to 309 entries in this database. 9. The updated prediction interface. The peptide prediction interface has been improved in the APD3. It now predicts the possibility of a sequence to be AMPs based on the entire parameter space defined by all the natural peptides registered in the database. This objective justifies our focus on natural AMPs with demonstrated activity so that this parameter space is not distorted by synthetic peptides or predicted sequences. 10. Statistical information. This database interface provides statistical information for peptide sequence, function and structure. The structural statistics has been mentioned above, while the AMP function statistics is summarized in Table 2 . For updated statistics, please visit the APD3. 11. Additional tools. To further expand the capability of the APD3, we created a web page My Tools, which provides 16 links to various online programs for helical wheel projection, as well as predictions of signal sequence in a pro-peptide, peptide half-life, instability index, alpha index, cell penetrating ability, antigenicity and 3D structure. 12. Web pages for education. The APD3 also contains multiple web pages for education purpose. The discovery timeline is an annual list of select AMPs with interesting features. Nomenclature lists four typical methods for AMP naming, while classification provides seven major methods for AMP classification. The 3D structure describes structure annotation, determination methods, classification, viewing, structure citation and statistics. Glossary provides definitions for commonly used AMP terms and abbreviations, including the BB and XX keys created for the APD3 search. FAQs provide answers to the frequently asked questions from users. Users can 
AMINO ACID PROFILES OR SIGNATURES OF AMPS FROM VARIOUS CLASSES
It is now recognized that the amino acid composition of AMPs is one of the most important parameters for peptide classification, prediction and design (9,31). To our knowledge, the APD is the first database that provides a program for calculations of the amino acid composition for AMPs from a variety of families (16) . A plot of the amino acid occurring frequency versus the 20 amino acids for a family of peptides generates the amino acid profile or signature. Select amino acid profiles for AMPs from different life groups (e.g. bacteria, plants, amphibians, birds, reptiles, fish and humans), activity groups (such as antibacterial, antiviral, antifungal and anticancer) and structure groups (␣, ␤, ␣␤ and non-␣␤), have been presented elsewhere (34) . Here we present the amino acid profiles for the four unified peptide classes (31) based on the data already annotated in the APD3 (Figure 1 ). The 694 linear AMPs (UCLL) are abundant (≥10%) in amino acids L, A, G and K. To view the differences between lantibiotics and defensins, we split the sidechain-connected UCSS class into UCSS1a and UCSS1b. While the disulfide-bond linked AMPs (UCSS1a) are abundant in C, G and K, the UCSS1b subclass (mainly lantibiotics) is abundant in C, T and S, which form multiple thioether bonds. As described elsewhere (31), the UCSS1a class can also be further divided into subclasses. The 306 defensins with a ␤-sheet structure are abundant in C, G and R. Cysteines and glycines are important structural residues, whereas arginines confer biological functions (9) . In the UCSS1a class, the abundant residues are L and K in the helical subclass containing three disulfide bonds. Another subclass contains the amphibian AMPs with a 'Rana box' stabilized by one disulfide bond. The abundant residues (L, A, G and K) of this subclass are identical to those of all amphibian AMPs (1007 entries) or a subset of 117 frog AMPs with a known helical structure. Interestingly, the third class UCSB, with a chemical bond between the side chain and peptide backbone (22 members), is abundant in V, A and G. Finally, the 189 circular AMPs in the UCBB class (with a peptide bond between the N and C termini) are abundant in C and G only. It is clear that the amino acid profile or signature depends on the peptide class ( Figure 1 ). In addition, these unified classes of AMPs in the APD3 also vary in average peptide length and net charge (Table  4) . While the average net charge is in the following order: UCSS1a > UCLL > UCSS1b > UCBB > UCSB, the order for the average peptide length is UCSS1a > UCBB > UCSS1b > UCLL > UCSB. It is interesting that the disulfide bond-linked AMPs (UCSS1a), most positive in net charge, are also longest on average. In contrast, the AMPs generated via a sidechain-backbone connection (i.e. the UCSB class) are not only shortest in length but also lowest in net charge (Table 4) . Such derived net charges, lengths and abundant amino acids ( Figure 1 and Table 4) can be useful for predicting or designing AMPs from different classes.
APPLICATIONS OF THE APD IN RESEARCH AND ED-UCATION
Since its publication in Nucleic Acids Research in 2004 (16), the APD has been utilized for a variety of purposes. In the following, we highlight some of these applications.
1. Information search. This is the basic function of this database. Users can search peptide sequence, source, activity, structure, chemical modification, peptide properties (such as net charge, length, hydrophobic%, binding partners), the year of publication, author, mechanism of action and more. 2. Peptide property calculations. In addition to peptide length, net charge, amino acid composition and Boman index previously programmed in the APD (16), the APD3 enabled the calculations of molecular weight, molecular formula, molar extinction coefficient and GRAVY (35). 3. Peptide classification method development. As described above, the APD also enabled us to propose unified classification schemes for 3D structures as well as sequences of AMPs (9,31). Table 4 . bactofencin A using the BLAST database, but identified similar sequences in the APD2. 5. AMP statistics. The APD3 provides an average net charge of +3.2 and length of 32.7 based on the 2619 AMPs. Additional general features of AMPs can be found on the AMP Facts. These statistical parameters are useful for describing the general properties of AMPs (see also Figure 1 and Table 4 ). 6. Cleavage sequence selection for recombinant AMP expression. In the APD3, there were 754 AMPs containing a methionine residue (M) and only 76 peptides containing a DP pair. Such a dramatic difference formed the basis for our previous creation of a DP sequence as a cleavage site to release the recombinant form of human cathelicidin LL-37 from the expressed fusion protein by formic acid (37) . Because less AMPs contain the DP site than M, this cleavage site can have a broader application in expression and purification of AMPs with a native sequence (38). 7. Template selection for structure-activity relationship (SAR) studies. To understand why a bacterial membrane anchor is not toxic, we used the APD to identify aurein 1.2 that shares the N-terminal GLFD sequence with the membrane anchor (39) . This study revealed the importance of peptide length or hydrophobicity for peptide activity.
Peptide property improvements.
Based on the arginine/lysine ratio in AMPs with different activities, the antiviral peptides were found to have the highest arginine content compared to other activity groups. This finding enabled us to improve anti-HIV activity of known AMPs by introducing additional arginines (40). 9. Peptide design. Based on the 525 entries in the APD (16), Loose developed the Grammar approach (41) . Using the APD2, we developed a database filtering technology for peptide design (42) . By combining the most probable parameters derived from the database, we were able to obtain a potent peptide against methicillinresistant S. aureus (MRSA). This topic has recently been reviewed (32 In summary, the potential applications of the APD3 are beyond our descriptions above. With continued expansion and improvements of the database, new applications will become possible or conceived.
COMPLEMENTARY FEATURES FROM OTHER DATABASES
Since the publication of the APD in 2004, multiple databases have been constructed with narrower or wider scopes (For a recent review, see 49). These databases can be accessed via the Links of the APD3. Databases with a narrower scope may contain additional information. Examples are BACTIBASE for bacteriocins, PhytAMP for plant AMPs, DADP for amphibian peptides and PenBase for shrimp AMPs (18) (19) (20) (21) (22) . There are also databases for special types of AMPs such as Defensins Knowledgebase for defensins and Cybase for circular polypeptides (23, 24) . Some recent databases have collected other sequences. While CAMPR3 (27) collected 5390 predicted sequences without activity data, DBAASP2 collected ∼6000 synthetic peptides (accessed in October 2015) (50) . These databases can be useful when there is a need for such types of sequences. However, predicted sequences may not be true AMPs. For example, Yang et al. (51) recently synthesized multiple predicted peptides and found little or no antimicrobial activity, while most of the isolated peptides are true AMPs.
CONCLUDING REMARKS
It is evident that the AMP research has its niche in the 'omics' age. Up or down regulation of AMPs is related to various human diseases (3) (4) (5) . Together, AMPs from the host, commensal bacteria and invading pathogens shape our microbiota that can be linked to various human diseases (52). As we illustrated above, the construction of wellannotated AMP databases is helpful to the researchers in the field. During the past 13 years, the APD has been expanded and regularly updated. The 2619 AMP entries in the current APD3 are almost five times those in the original APD. The APD3 registers peptides by following a set of criteria (i.e. natural AMPs with a known sequence, activity and size less than 200 amino acids). We hope that such a well-registered data set can facilitate our effort in deciphering nature's design principles of AMPs. For this goal, it is necessary not to mix natural AMPs with synthetic peptides so that the underlying features would not be masked, diluted or even distorted. We also decided to postpone collecting predicted sequences at this stage because such sequences may not be true AMPs. Because there are different numbers of peptides in other databases (15, (18) (19) (20) (21) (22) (23) (24) (25) (26) (27) , it is useful to address the following question before closing. How many AMPs with known activity have we discovered from natural sources as of Oct 2015? There are ≈2600 such AMPs based on the APD3. Indeed, a comparative analysis of over 10 AMP databases in 2014 revealed 2497 natural sequences with validated antimicrobial activity (53) , which corresponded closely to the total number of the AMPs in our database then. We predict that the final number of natural AMPs will be at least in the million range if 1.3 million named species can each produce at least one such peptide. In conclusion, the APD3 is a comprehensive database for peptide discovery chronicle, nomenclature, classification, information search, calculations, prediction and design of AMPs. It emphasizes accuracy, uniqueness, unification, integration and user-friendliness. This database can be accessed in the same website (http://aps.unmc.edu/AP).
